CorVel Corp. (CRVL)

58.52 +0.38 (+0.66%) USD  |  NASDAQ  |  Jun 18, 16:00
58.56 +0.04 (+0.06%) After-Hours: 20:00
More

CorVel SG&A Expense (Quarterly) : 23.29M for March 31, 2026

SG&A Expense (Quarterly) Chart

View SG&A Expense (Quarterly) for CRVL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (Quarterly) Chart
Start Trial

Historical SG&A Expense (Quarterly) Data

View and export this data back to 1996. Start Trial.
Date Value
March 31, 2026 23.29M
December 31, 2025 22.68M
September 30, 2025 22.28M
June 30, 2025 21.48M
March 31, 2025 24.65M
December 31, 2024 22.06M
September 30, 2024 22.08M
June 30, 2024 20.12M
March 31, 2024 20.81M
December 31, 2023 19.80M
September 30, 2023 19.54M
June 30, 2023 16.45M
March 31, 2023 19.36M
December 31, 2022 18.13M
September 30, 2022 17.55M
June 30, 2022 18.67M
March 31, 2022 16.79M
December 31, 2021 17.51M
September 30, 2021 16.66M
June 30, 2021 16.64M
March 31, 2021 16.37M
December 31, 2020 16.94M
September 30, 2020 15.56M
June 30, 2020 15.58M
March 31, 2020 15.86M
Date Value
December 31, 2019 17.00M
September 30, 2019 16.59M
June 30, 2019 15.75M
March 31, 2019 16.46M
December 31, 2018 15.80M
September 30, 2018 15.09M
June 30, 2018 15.94M
March 31, 2018 15.55M
December 31, 2017 15.50M
September 30, 2017 13.67M
June 30, 2017 14.63M
March 31, 2017 15.00M
December 31, 2016 14.13M
September 30, 2016 14.64M
June 30, 2016 13.46M
March 31, 2016 15.81M
December 31, 2015 14.50M
September 30, 2015 13.21M
June 30, 2015 14.96M
March 31, 2015 13.62M
December 31, 2014 13.83M
September 30, 2014 12.75M
June 30, 2014 14.20M
March 31, 2014 13.70M
December 31, 2013 13.20M

SG&A Expense (Quarterly) Range, Past 5 Years

View SG&A Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (Quarterly) Benchmarks

View SG&A Expense (Quarterly) Benchmarks
Start Trial
MSP Recovery, Inc. 4.935M
The Cigna Group 0.00
Centene Corp. 0.00
CVS Health Corp. 10.94B
Humana, Inc. 0.00